
11.18 Delayed Data As of May 19 | ![]() Today’s Change | 7.26 Today|||52-Week Range 21.39 | -20.54% Year-to-Date |
Why Dynavax Stock Blasted 16% Higher Today May 19 / MotleyFool.com - Paid Partner Content | Why Dynavax Stock Won on a Losing Monday for the Market May 16 / MotleyFool.com - Paid Partner Content |
Previous close | 9.62 |
Today’s open | 9.62 |
Day’s range | 9.62 - 11.26 |
Volume | 267,040 |
Average volume (3 months) | 2,317,132 |
Market cap | $1.2B |
Earnings growth (last year) | -- |
Earnings growth (this year) | +124.21% |
Earnings growth (next 5 years) | -- |
Revenue growth (last year) | +838.85% |
P/E ratio | 14.3 |
Price/Sales | 4.28 |
Price/Book | 5.29 |
Today’s change | Today’s % change | |
---|---|---|
AXSMAxsome Therapeutics ... | +0.40 | +1.28% |
PRTAProthena Corporation... | +0.68 | +2.66% |
SRRASierra Oncology Inc | +0.06 | +0.11% |
XNCRXencor Inc | +0.45 | +2.00% |
Next reporting date | August 10, 2022 |
EPS forecast (this quarter) | $0.29 |
Annual revenue (last year) | $437.0M |
Annual profit (last year) | $72.1M |
Net profit margin | 16.51% |
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Emeryville, California |